← FDA DRUG APPROVALS

FDA ANDA · ANDA064159

CLINDAMYCIN PHOSPHATE

Sponsor: FOUGERA PHARMS INC

APPLICATION
ANDA064159
TYPE
ANDA
ORIGINAL APPROVAL
1997-06-05
LATEST ACTION
2025-08-22
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

CLINDAMYCIN PHOSPHATEPrescription
CLINDAMYCIN PHOSPHATE EQ 1% BASE · SOLUTION · TOPICAL

Approval history

2025-08-22Labeling · Supplement 17 · standardAP
2025-08-22Labeling · Supplement 13 · standardAP
2025-08-22Labeling · Supplement 16 · standardAP
2025-08-22Labeling · Supplement 20 · standardAP
2025-08-22Labeling · Supplement 19 · standardAP
2005-06-02Labeling · Supplement 4AP
2004-06-16Labeling · Supplement 2AP
2001-02-26Manufacturing (CMC) · Supplement 1AP
1997-06-05OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →